Pharmsville (Korea) Performance
318010 Stock | KRW 4,385 90.00 2.01% |
The company holds a Beta of 0.41, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pharmsville's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharmsville is expected to be smaller as well. At this point, Pharmsville has a negative expected return of -0.24%. Please make sure to check Pharmsville's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Pharmsville performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Pharmsville Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Total Cashflows From Investing Activities | -2.6 B |
Pharmsville |
Pharmsville Relative Risk vs. Return Landscape
If you would invest 539,000 in Pharmsville Co on September 3, 2024 and sell it today you would lose (100,500) from holding Pharmsville Co or give up 18.65% of portfolio value over 90 days. Pharmsville Co is generating negative expected returns and assumes 5.0425% volatility on return distribution over the 90 days horizon. Simply put, 44% of stocks are less volatile than Pharmsville, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Pharmsville Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmsville's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pharmsville Co, and traders can use it to determine the average amount a Pharmsville's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0467
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 318010 |
Estimated Market Risk
5.04 actual daily | 44 56% of assets are more volatile |
Expected Return
-0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pharmsville is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharmsville by adding Pharmsville to a well-diversified portfolio.
Pharmsville Fundamentals Growth
Pharmsville Stock prices reflect investors' perceptions of the future prospects and financial health of Pharmsville, and Pharmsville fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmsville Stock performance.
Return On Equity | 5.4 | |||
Return On Asset | 0.0305 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 61.69 B | |||
Revenue | 39.03 B | |||
EBITDA | 3.65 B | |||
Cash And Equivalents | 14.03 B | |||
Total Debt | 5.35 B | |||
Debt To Equity | 0.15 % | |||
Cash Flow From Operations | 8.27 B | |||
Total Asset | 74.31 B | |||
About Pharmsville Performance
By analyzing Pharmsville's fundamental ratios, stakeholders can gain valuable insights into Pharmsville's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharmsville has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmsville has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Pharmsville Co., Ltd. produces and sells functional health foods in South Korea. Pharmsville Co., Ltd. was founded in 2000 and headquartered in Seoul. Pharmsville is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Pharmsville performance evaluation
Checking the ongoing alerts about Pharmsville for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharmsville help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Pharmsville generated a negative expected return over the last 90 days | |
Pharmsville has high historical volatility and very poor performance | |
About 71.0% of the company shares are owned by insiders or employees |
- Analyzing Pharmsville's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmsville's stock is overvalued or undervalued compared to its peers.
- Examining Pharmsville's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmsville's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmsville's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharmsville's stock. These opinions can provide insight into Pharmsville's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pharmsville Stock analysis
When running Pharmsville's price analysis, check to measure Pharmsville's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmsville is operating at the current time. Most of Pharmsville's value examination focuses on studying past and present price action to predict the probability of Pharmsville's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmsville's price. Additionally, you may evaluate how the addition of Pharmsville to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |